Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beta Bionics
MedTech
Artificial pancreas maker Beta Bionics sets IPO goal of $120M
The company is set to begin trading on the Nasdaq between $14 and $16 per share—a range that would give Beta Bionics about a $625 million valuation.
Conor Hale
Jan 22, 2025 11:20am
Fierce Medtech's Fierce 15 of 2023
Mar 4, 2024 3:00am
Dexcom taps Beta Bionics as 2nd G7 sensor partner this week
Dec 8, 2023 11:05am
Beta Bionics brings in $100M to expand artificial pancreas tech
Aug 31, 2023 10:37am
FDA clears Beta Bionics' artificial pancreas system
May 22, 2023 10:06am
ADA: Beta Bionics artificial pancreas cuts blood sugar in study
Jun 10, 2022 1:35pm
